Elizabethkingia meningoseptica infection in a geriatric patient with other recurrent bacterial infections

Q3 Neuroscience

eNeurologicalSci Pub Date : 2025-07-10 DOI:10.1016/j.ensci.2025.100576

Luis Castañeda Pelaez , Jesús Eduardo Rojas Jaimes , Elsa Nuñez Infanzón , Delza Tárraga Gonzales , Sergio Ronceros Medrano

引用次数: 0

Abstract

Elizabethkingia meningoseptica is a Gram-negative bacillary bacterium known for its multidrug resistance, particularly to carbapenems. This resistance complicates treatment and results in a high mortality rate, especially in hospitalized patients, which can reach up to 52 %. In this case, the infection was observed in a 73-year-old immunocompetent patient with a chronic exacerbated subdural hemorrhage with midline deviation and tracheostomy, who was hospitalized and febrile, and the bacterium Elizabethkingia meningoseptica was isolated in bronchial secretion cultures. The patient responded favorably to treatment with sulfamethoxazole/trimethoprim and other recurrent infections caused by Klebsiella pneumoniae, Stenotrophomonas maltophilia, and Pseudomonas aeruginosa. Ultimately, the immunocompetent patient improved and was discharged, able to ventilate independently.

查看原文本刊更多论文

老年患者伊莉莎白氏脑膜炎败血症感染伴其他复发性细菌感染

伊莉莎白氏脑膜炎败血症是一种革兰氏阴性杆菌，以其耐多药而闻名，特别是对碳青霉烯类。这种耐药性使治疗复杂化，并导致高死亡率，特别是住院患者的死亡率可高达52%。在本病例中，73岁免疫功能正常的患者，慢性加重硬膜下出血，中线偏离，气管造口，住院并发热，在支气管分泌物培养中分离到elizabeth ethkingia脑膜炎脓毒杆菌。患者对磺胺甲恶唑/甲氧苄啶治疗及其他由肺炎克雷伯菌、嗜麦芽窄养单胞菌和铜绿假单胞菌引起的复发感染反应良好。最终，患者的免疫功能得到改善并出院，能够独立呼吸。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

eNeurologicalSci Neuroscience-Neurology

CiteScore

3.50

自引率

0.00%

发文量

审稿时长

62 days

期刊介绍： eNeurologicalSci provides a medium for the prompt publication of original articles in neurology and neuroscience from around the world. eNS places special emphasis on articles that: 1) provide guidance to clinicians around the world (Best Practices, Global Neurology); 2) report cutting-edge science related to neurology (Basic and Translational Sciences); 3) educate readers about relevant and practical clinical outcomes in neurology (Outcomes Research); and 4) summarize or editorialize the current state of the literature (Reviews, Commentaries, and Editorials). eNS accepts most types of manuscripts for consideration including original research papers, short communications, reviews, book reviews, letters to the Editor, opinions and editorials. Topics considered will be from neurology-related fields that are of interest to practicing physicians around the world. Examples include neuromuscular diseases, demyelination, atrophies, dementia, neoplasms, infections, epilepsies, disturbances of consciousness, stroke and cerebral circulation, growth and development, plasticity and intermediary metabolism. The fields covered may include neuroanatomy, neurochemistry, neuroendocrinology, neuroepidemiology, neurogenetics, neuroimmunology, neuroophthalmology, neuropathology, neuropharmacology, neurophysiology, neuropsychology, neuroradiology, neurosurgery, neurooncology, neurotoxicology, restorative neurology, and tropical neurology.